Cumulus to participate in The Digital Health Measurement Collaborative Community (DATAcc) by DiMe project – Building the Business Case for...
Data-centric organizations in healthcare, financial, and travel services trust Scality RING as the foundation for AI-powered data lakes SAN FRANCISCO, June...
Co-founder and previous CEO Lowry Curley becomes Chief Scientific Officer NEW ORLEANS, June 11, 2024 /PRNewswire/ -- AxoSim, a life...
Toronto, Ontario--(Newsfile Corp. - June 11, 2024) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light...
ZURICH, SWITZERLAND / ACCESSWIRE / June 11, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage...
AGOURA HILLS, Calif., June 11, 2024 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) announced today its CEO- Dr. Vuong Trieu...
With Growing Body of Clinical Evidence, ALX-001 is Ready to Commence Phase 2 StudiesNEW HAVEN, Conn., June 11, 2024 (GLOBE...
Publication Highlights Activity of the Combination of TRC102 and Temodar (Temozolomide) in Patients who Progressed Following Initial Treatment with Surgical...
Join Our Investor Call for In-Depth Findings Discussion Efficacy in Early AD Patients Buntanetap showed statistically significant efficacy and safety...
GOTHENBURG, SWEDEN / ACCESSWIRE / June 11, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, June 11, 2024 - IRLAB Therapeutics...
SAN MATEO, Calif., June 10, 2024 /PRNewswire/ -- Cala, the bioelectronic medicine leader, reached a major milestone: a positive Medicare...
Board consists of key opinion leaders from both clinical practice and academia with strong track records in the development of...
June 10, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Twelve month Phase 2 Clinical Trial Results of eRapa™ in Familial...
Preclinical data highlights the therapeutic potential of Ashvattha’s novel CSF1R tyrosine kinase inhibitor (CSF1R dendranib) for multiple sclerosis (MS) based...
Global early-stage fund to catalyze development of the next generation of treatments Backers include the leading spinal cord injury foundations...
ORLANDO, Fla., June 7, 2024 /PRNewswire/ -- Monotype, one of the most recognized names in the world of fonts and...
CARMEL, Ind., June 07, 2024 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology...
MUNICH, June 6, 2024 /PRNewswire/ -- According to the World Health Organization (WHO), at least 80 million people (or 1%...
MOUNTAIN VIEW, Calif., June 6, 2024 /PRNewswire/ -- NextSense is proud to announce that it has been recognized as a...
New Longevity Tech Collaboration Will Research and Develop First-Ever Biological Clock for the Brain WHISTLER, BC, June 6, 2024 /PRNewswire/...